NasdaqCM - Nasdaq Real Time Price USD
ENDRA Life Sciences Inc. (NDRA)
3.4501
-0.3299
(-8.73%)
At close: April 24 at 4:00:00 PM EDT
3.5300
+0.08
+(2.32%)
After hours: April 24 at 7:30:07 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 1,622,356 | 53 |
Sales | 415,469 | 12 |
Net Shares Purchased (Sold) | 1,206,887 | 65 |
Total Insider Shares Held | 775 | -- |
% Net Shares Purchased (Sold) | -100.10% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
UBS GROUP AG Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.55 per share. | Indirect | 2,052 | Aug 27, 2024 |
THORNTON MICHAEL MILOS Chief Technology Officer | Purchase at price 1.65 per share. | Direct | 24,750 | May 18, 2023 |
DIGIANDOMENICO ANTHONY Director | Purchase at price 1.20 per share. | Direct | 100,000 | May 2, 2023 |
Related Tickers
APDN Applied DNA Sciences, Inc.
0.8620
-0.21%
PRPO Precipio, Inc.
6.73
-12.60%
ISPC iSpecimen Inc.
1.2150
+2.10%
PRPH ProPhase Labs, Inc.
0.3352
-5.10%
MYNZ Mainz Biomed N.V.
3.2000
+1.59%
BIAF bioAffinity Technologies, Inc.
0.5120
+2.61%
BDSX Biodesix, Inc.
0.5712
+15.35%
NEOG Neogen Corporation
5.20
+5.69%
ACRS Aclaris Therapeutics, Inc.
1.2700
+6.72%
TTOO T2 Biosystems, Inc.
0.1100
-0.99%